Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review
Advanced Biology · 2023-08 · 7 (8)
DOI: 10.1002/adbi.202300086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, online erschienen am 13.05.2023. Verfasst von Lin Guan und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, P. R. China. Hauptthemen laut MEDLINE: Antimalarials, Artemisinins, Malaria, Folic Acid Antagonists. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: National Basic Research Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Artemisinin (ART) and its derivatives have great therapeutical utility as antimalarials and can be repurposed for other indications, such as viral infections, autoimmune diseases, and cancer. This review presents a comprehensive overview of the therapeutic effects of ART‐based drugs, beyond their antimalarial effects. This review also summarizes the information on their repurposing in other pathologies, with the hope that it will guide the future optimization of the use of ART‐based drugs and of the treatment strategies for the listed diseases. By reviewing related literature, ART extraction and structure as well as the synthesis and structure of its derivatives are presented. Subsequently, the traditional roles of ART and its derivatives against malaria are reviewed, including antimalarial mechanism and occurrence of antimalarial resistance. Finally, the potential of ART and its derivatives to be repurposed for the treatment of other diseases are summarized. The great repurposing potential of ART and its derivatives may be useful for the control of emerging diseases with corresponding pathologies, and future research should be directed toward the synthesis of more effective derivatives or better combinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
- Wuhan Humanwell Pharmaceutical Co. Ltd., Wuhan, 430206, P. R. China.
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing, 100010, P. R. China.
ORCID-Profile: Huahao Fan
Förderung
- National Basic Research Program of China
- National Natural Science Foundation of China
Zitieren
APA
Guan, L., Wang, H., Xu, X., & Fan, H. (2023). Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review. Advanced Biology, 7(8). https://doi.org/10.1002/adbi.202300086
Vancouver
Guan L, Wang H, Xu X, Fan H. Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review. Advanced Biology. 2023;7(8). doi:10.1002/adbi.202300086
BibTeX
@article{Guan2023,
author = {Guan, Lin and Wang, Huiyong and Xu, Xiaolong and Fan, Huahao},
title = {Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review},
journal = {Advanced Biology},
year = {2023},
volume = {7},
number = {8},
doi = {10.1002/adbi.202300086}
}
EUVIMED